Literature DB >> 19666518

A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia.

Wei Tian1, Yi Fu, Anna Garcia-Elias, José M Fernández-Fernández, Rubén Vicente, Patricia L Kramer, Robert F Klein, Robert Hitzemann, Eric S Orwoll, Beth Wilmot, Shannon McWeeney, Miguel A Valverde, David M Cohen.   

Abstract

Disorders of water balance are among the most common and morbid of the electrolyte disturbances, and are reflected clinically as abnormalities in the serum sodium concentration. The transient receptor potential vanilloid 4 (TRPV4) channel is postulated to comprise an element of the central tonicity-sensing mechanism in the mammalian hypothalamus, and is activated by hypotonic stress in vitro. A nonsynonymous polymorphism in the TRPV4 gene gives rise to a Pro-to-Ser substitution at residue 19. We show that this polymorphism is significantly associated with serum sodium concentration and with hyponatremia (serum sodium concentration < or =135 mEq/L) in 2 non-Hispanic Caucasian male populations; in addition, mean serum sodium concentration is lower among subjects with the TRPV4(P19S) allele relative to the wild-type allele. Subjects with the minor allele were 2.4-6.4 times as likely to exhibit hyponatremia as subjects without the minor allele (after inclusion of key covariates). Consistent with these observations, a human TRPV4 channel mutated to incorporate the TRPV4(P19S) polymorphism showed diminished response to hypotonic stress (relative to the wild-type channel) and to the osmotransducing lipid epoxyeicosatrienoic acid in heterologous expression studies. These data suggest that this polymorphism affects TRPV4 function in vivo and likely influences systemic water balance on a population-wide basis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666518      PMCID: PMC2729015          DOI: 10.1073/pnas.0904084106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

2.  Dual role of the TRPV4 channel as a sensor of flow and osmolality in renal epithelial cells.

Authors:  Ling Wu; Xiaochong Gao; Rachel C Brown; Stefan Heller; Roger G O'Neil
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-15

3.  Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

Authors:  Robert W Schrier; Peter Gross; Mihai Gheorghiade; Tomas Berl; Joseph G Verbalis; Frank S Czerwiec; Cesare Orlandi
Journal:  N Engl J Med       Date:  2006-11-14       Impact factor: 91.245

4.  IP3 receptor binds to and sensitizes TRPV4 channel to osmotic stimuli via a calmodulin-binding site.

Authors:  Anna Garcia-Elias; Ivan M Lorenzo; Rubén Vicente; Miguel A Valverde
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

Review 5.  Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia.

Authors:  Juan Carlos Ayus; Steven G Achinger; Allen Arieff
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-30

6.  Regulation of the epithelial Mg2+ channel TRPM6 by estrogen and the associated repressor protein of estrogen receptor activity (REA).

Authors:  Gang Cao; Jenny van der Wijst; Annemiete van der Kemp; Femke van Zeeland; René J Bindels; Joost G Hoenderop
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

7.  Tyrosine phosphorylation modulates the activity of TRPV4 in response to defined stimuli.

Authors:  Tomasz Wegierski; Urs Lewandrowski; Barbara Müller; Albert Sickmann; Gerd Walz
Journal:  J Biol Chem       Date:  2008-11-25       Impact factor: 5.157

Review 8.  Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management.

Authors:  Myron Miller
Journal:  J Am Geriatr Soc       Date:  2006-02       Impact factor: 5.562

9.  Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor.

Authors:  W Liedtke; Y Choe; M A Martí-Renom; A M Bell; C S Denis; A Sali; A J Hudspeth; J M Friedman; S Heller
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

10.  IP3 sensitizes TRPV4 channel to the mechano- and osmotransducing messenger 5'-6'-epoxyeicosatrienoic acid.

Authors:  Jacqueline Fernandes; Ivan M Lorenzo; Yaniré N Andrade; Anna Garcia-Elias; Selma A Serra; José M Fernández-Fernández; Miguel A Valverde
Journal:  J Cell Biol       Date:  2008-03-31       Impact factor: 10.539

View more
  42 in total

1.  Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effects.

Authors:  Beth Wilmot; V Saroja Voruganti; Yen-Pei C Chang; Yi Fu; Zhan Chen; Herman A Taylor; James G Wilson; Teresa Gipson; Vallabh O Shah; Jason G Umans; Michael F Flessner; Robert Hitzemann; Alan R Shuldiner; Anthony G Comuzzie; Shannon McWeeney; Philip G Zager; Jean W Maccluer; Shelley A Cole; David M Cohen
Journal:  Physiol Genomics       Date:  2011-12-20       Impact factor: 3.107

2.  Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: age- and sex-dependent progression of osteoarthritis in Trpv4-deficient mice.

Authors:  Andrea L Clark; Bartholomew J Votta; Sanjay Kumar; Wolfgang Liedtke; Farshid Guilak
Journal:  Arthritis Rheum       Date:  2010-10

3.  American Society of Nephrology Quiz and Questionnaire 2015: Electrolytes and Acid-Base Disorders.

Authors:  Mitchell H Rosner; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-29       Impact factor: 8.237

Review 4.  Transient receptor potential channelopathies.

Authors:  Bernd Nilius; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2010-02-04       Impact factor: 3.657

Review 5.  Ion channels in asthma.

Authors:  Miguel A Valverde; Gerard Cantero-Recasens; Anna Garcia-Elias; Carole Jung; Amado Carreras-Sureda; Rubén Vicente
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

6.  Swelling and eicosanoid metabolites differentially gate TRPV4 channels in retinal neurons and glia.

Authors:  Daniel A Ryskamp; Andrew O Jo; Amber M Frye; Felix Vazquez-Chona; Nanna MacAulay; Wallace B Thoreson; David Križaj
Journal:  J Neurosci       Date:  2014-11-19       Impact factor: 6.167

7.  TRPV4 participates in the establishment of trailing adhesions and directional persistence of migrating cells.

Authors:  Sanela Mrkonjić; Anna Garcia-Elias; Carlos Pardo-Pastor; Elsa Bazellières; Xavier Trepat; Joris Vriens; Debapriya Ghosh; Thomas Voets; Rubén Vicente; Miguel A Valverde
Journal:  Pflugers Arch       Date:  2015-01-06       Impact factor: 3.657

Review 8.  Deciphering physiological role of the mechanosensitive TRPV4 channel in the distal nephron.

Authors:  M Mamenko; O Zaika; N Boukelmoune; R G O'Neil; O Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-10

9.  Associations between TRPV4 genotypes and body mass index in Taiwanese subjects.

Authors:  De-Min Duan; Semon Wu; Lung-An Hsu; Ming-Sheng Teng; Jeng-Feng Lin; Yu-Chen Sun; Ching-Feng Cheng; Yu-Lin Ko
Journal:  Mol Genet Genomics       Date:  2015-02-03       Impact factor: 3.291

10.  NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality.

Authors:  Carsten A Böger; Mathias Gorski; Gearoid M McMahon; Huichun Xu; Yen-Pei C Chang; Peter J van der Most; Gerjan Navis; Ilja M Nolte; Martin H de Borst; Weihua Zhang; Benjamin Lehne; Marie Loh; Sian-Tsung Tan; Eric Boerwinkle; Morgan E Grams; Peggy Sekula; Man Li; Beth Wilmot; James G Moon; Paul Scheet; Francesco Cucca; Xiangjun Xiao; Leo-Pekka Lyytikäinen; Graciela Delgado; Tanja B Grammer; Marcus E Kleber; Sanaz Sedaghat; Fernando Rivadeneira; Tanguy Corre; Zoltan Kutalik; Sven Bergmann; Carrie M Nielson; Priya Srikanth; Alexander Teumer; Martina Müller-Nurasyid; Anne Catharina Brockhaus; Arne Pfeufer; Wolfgang Rathmann; Annette Peters; Martha Matsumoto; Mariza de Andrade; Elizabeth J Atkinson; Cassianne Robinson-Cohen; Ian H de Boer; Shih-Jen Hwang; Iris M Heid; Martin Gögele; Maria Pina Concas; Toshiko Tanaka; Stefania Bandinelli; Mike A Nalls; Andrew Singleton; Salman M Tajuddin; Adebowale Adeyemo; Jie Zhou; Ayo Doumatey; Shannon McWeeney; Joanne Murabito; Nora Franceschini; Michael Flessner; Michael Shlipak; James G Wilson; Guanjie Chen; Charles N Rotimi; Alan B Zonderman; Michele K Evans; Luigi Ferrucci; Olivier Devuyst; Mario Pirastu; Alan Shuldiner; Andrew A Hicks; Peter Paul Pramstaller; Bryan Kestenbaum; Sharon L R Kardia; Stephen T Turner; LifeLines Cohort Study; Tamara Ellefson Briske; Christian Gieger; Konstantin Strauch; Christa Meisinger; Thomas Meitinger; Uwe Völker; Matthias Nauck; Henry Völzke; Peter Vollenweider; Murielle Bochud; Gerard Waeber; Mika Kähönen; Terho Lehtimäki; Winfried März; Abbas Dehghan; Oscar H Franco; Andre G Uitterlinden; Albert Hofman; Herman A Taylor; John C Chambers; Jaspal S Kooner; Caroline S Fox; Robert Hitzemann; Eric S Orwoll; Cristian Pattaro; David Schlessinger; Anna Köttgen; Harold Snieder; Afshin Parsa; David M Cohen
Journal:  J Am Soc Nephrol       Date:  2017-03-30       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.